Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Rubius Therapeutics, Inc. (RUBY)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.8 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -364.5% | -167.7% | -76.2% | -76.9% | -107.2% | -2727.8% | |
ROIC (including intangibles) | -12608.3% | -282.8% | -101.9% | -61.9% | -54.8% | -1203.7% | 2569.7% |
ROE | -841.0% | -108.9% | -117.6% | -61.9% | -23.3% | -45.0% | -558.5% |
ROA | -551.6% | -61.2% | -59.9% | -43.0% | -19.1% | -40.2% | -135.8% |
|
Cash Conversion Cycle |
Days sales outstanding | | | | | 0.0 | 0.0 | |
|